• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Enhanced surveillance and investigation of coronavirus: what is required? (WHO/EMRO, abstract)

Giuseppe

Emeritus
[Source: Eastern Mediterranean Health Journal, full PDF document: http://applications.emro.who.int/emhj/v19/Supp1/EMHJ_2013_19_Supp1_S55_S60.pdf. Abstract, edited.]


Short communication

Enhanced surveillance and investigation of coronavirus: what is required?

R.G. Pebody,1 A. Nicoll,2 U. Buchholz,3 M. Zambon1 and A. Mounts4


(1)Public Health England, London, United Kingdom (Correspondence to R.G. Pebody: richard.pebody@phe.gov.uk). (2)European Centre for Disease Prevention and Control, Stockholm, Sweden. (3)Robert Koch Institute, Berlin, Germany. (4)Global Influenza Programme,World Health Organization, Geneva, Switzerland.


ABSTRACT

Following the discovery in September 2012 of 2 patients, both with links to the Eastern Mediterranean Region, with serious respiratory illness due to novel coronavirus, all countries have instigated surveillance and laboratory activities to detect further cases, with intensive case−contact investigations undertaken on laboratory confirmation of cases. A total of 30 cases, of whom 18 have died, and at least 3 clusters have been detected to date (1 cluster among health-care workers and another 2 clusters among family members). To date, transmission studies have shown a low risk of onward human transmission, with clinical presentation remaining severe for the majority. Many questions remain including the zoonotic source and geographical extent of infection. Surveillance has been extended to include clusters of cases or health-care workers with severe, undiagnosed respiratory illness regardless of travel history. Environmental studies, on-going surveillance and linked case−contact investigations will provide a critical role in answering some of these issues.


-
------
 
Back
Top